Cargando…
Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
The AKR1B10 (aldo-keto reductase family 1 member B10) gene has important functions in carcinogen-induced neoplasia. AKR1B10 is also expressed in type 2 reaction leprosy patients (R2). We measured the expression of AKR1B10 in the skin lesions of patients with leprosy by immunohistochemistry from biop...
Autores principales: | Soares, Cleverson T., Fachin, Luciana R. V., Trombone, Ana P. F., Rosa, Patricia S., Ghidella, Cássio C., Belone, Andrea F. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166685/ https://www.ncbi.nlm.nih.gov/pubmed/30320113 http://dx.doi.org/10.3389/fmed.2018.00263 |
Ejemplares similares
-
Angiogenesis and Lymphangiogenesis in the Spectrum of Leprosy and Its Reactional Forms
por: Soares, Cleverson Teixeira, et al.
Publicado: (2013) -
Differential Expression of MicroRNAs in Leprosy Skin Lesions
por: Soares, Cleverson T., et al.
Publicado: (2017) -
Genome-Wide Screening of mRNA Expression in Leprosy Patients
por: Belone, Andrea de Faria F., et al.
Publicado: (2015) -
qPCR detection of Mycobacterium leprae in biopsies and slit skin smear of different leprosy clinical forms
por: Azevedo, Michelle de Campos Soriani, et al.
Publicado: (2016) -
Editorial: Leprosy reactions: New knowledge on pathophysiology, diagnosis, treatment and prevention
por: Pinheiro, Roberta Olmo, et al.
Publicado: (2022)